There are many aspects to the U.S. health care system, as well as many different stakeholder viewpoints on how to address current challenges as our system shifts from one driven by the volume of health care services to one focused on the value of health care that is provided. As part of this shift, there is an increased interest in understanding how to measure value. Yet most of this interest is focused on only one aspect of health care costs—biopharmaceuticals—causing us to lose sight not only of how all aspects of the system work together, but of how we can ensure that patients’ views and needs are recognized.

The National Pharmaceutical Council’s ongoing research efforts work to define key elements of value and demonstrate their significance to health care stakeholders, while also broadly identifying both the barriers that prevent the full value generated by biopharmaceuticals from being realized and potential solutions to overcome those barriers.

Defining Value

As part of our health system's shift toward value and as a way to address health care costs, there is an increased interest in understanding how to assess the value of all aspects of health care. But how should value be defined?

Measuring Value

Measuring value is challenging, because it encompasses a wide variety of factors.